Search Results for: C5

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel LIMK1 LIM domain kinase 1
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • Sema3A PAK dependent Axon repulsion
  • Sema3A PAK dependent Axon repulsion
  • Sema4D induced cell migration and growth-cone collapse
  • RHO GTPases Activate ROCKs
  • RHO GTPases activate PAKs
  • Dabrafenib
  • Fostamatinib
Novel LRSAM1 leucine rich repeat and sterile alpha motif containing 1
  • Antigen processing: Ubiquitination & Proteasome degradation
Novel NEK6 NIMA related kinase 6
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Pore Complex (NPC) Disassembly
  • EML4 and NUDC in mitotic spindle formation
Novel PIGP phosphatidylinositol glycan anchor biosynthesis class P
  • Synthesis of glycosylphosphatidylinositol (GPI)
Novel PRDM16 PR/SET domain 16
  • PKMTs methylate histone lysines
  • Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
Novel PRKCZ protein kinase C zeta
  • GPVI-mediated activation cascade
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • VEGFR2 mediated cell proliferation
  • RHO GTPases Activate NADPH Oxidases
  • Estrogen-stimulated signaling through PRKCZ
  • Estrogen-stimulated signaling through PRKCZ
  • Tamoxifen
  • Staurosporine
  • Dequalinium
  • Benzoyl peroxide
Novel SARDH sarcosine dehydrogenase
  • Choline catabolism
Novel SLC10A2 solute carrier family 10 member 2
  • Recycling of bile acids and salts
  • Volixibat
  • Maralixibat
  • Odevixibat
  • Primary bile acid malabsorption
Novel SPTAN1 spectrin alpha, non-erythrocytic 1
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Nephrin family interactions
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • RAF/MAP kinase cascade
  • Neutrophil degranulation
  • COPI-mediated anterograde transport
  • RHOU GTPase cycle
  • RHOV GTPase cycle
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
  • Early infantile epileptic encephalopathy; Ohtahara syndrome
ANKS6 ankyrin repeat and sterile alpha motif domain containing 6
AQP6 aquaporin 6
  • Passive transport by Aquaporins
C2 complement C2
  • Initial triggering of complement
  • Activation of C3 and C5
  • Regulation of Complement cascade
  • Systemic lupus erythematosus
  • Classic complement pathway component defects, including the following eight diseases: C1q alpha-chain deficiency; C1q beta-chain deficiency; C1q gamma-chain deficiency; C1r deficiency; C1s deficiency; C2 deficiency; C3 deficiency; C4 deficiency
C3 complement C3
  • Alternative complement activation
  • Activation of C3 and C5
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Peptide ligand-binding receptors
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (i) signalling events
  • Neutrophil degranulation
  • Post-translational protein phosphorylation
  • Purinergic signaling in leishmaniasis infection
  • Regulation of Complement cascade
  • Human immunoglobulin G
  • Zinc
  • S-Hydroxycysteine
  • Mirococept
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Pegcetacoplan
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
  • Classic complement pathway component defects, including the following eight diseases: C1q alpha-chain deficiency; C1q beta-chain deficiency; C1q gamma-chain deficiency; C1r deficiency; C1s deficiency; C2 deficiency; C3 deficiency; C4 deficiency
C5AR1 complement C5a receptor 1
  • Peptide ligand-binding receptors
  • G alpha (i) signalling events
  • Neutrophil degranulation
  • Regulation of Complement cascade
  • Avacopan
C6 complement C6
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C7 complement C7
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C8B complement C8 beta chain
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Zinc
  • Copper
  • Zinc acetate
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
CPB2 carboxypeptidase B2
  • Metabolism of Angiotensinogen to Angiotensins
  • Regulation of Complement cascade
  • AZD-9684
  • Prothrombin
CPLX4 complexin 4
CPN1 carboxypeptidase N subunit 1
  • Regulation of Complement cascade
  • Zinc
  • ORE-1001
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form

Page 1 out of 2 pages